KDOQI (Kidney Disease Outcomes Quality Initiative)


NKF KDOQI GUIDELINES

Executive Summaries | Anemia | Hemodialysis | Peritoneal Dialysis |
Vascular Access | Nutrition | CKD 2002 | Dyslipidemias | Bone Metabolism | Hypertension and Antihypertensive Agents | Cardiovascular Disease in Dialysis Patients | History of KDOQI |

KDOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients


Figures

Figure 1. Estimated Mortality of Dialysis Patients after Acute MI

Figure 2. Estimated All-Cause Survival of Dialysis Patients after CABG, PTCA, and Stenting

Figure 3. Estimated All-Cause Survival of Dialysis Patients after Heart Valve Replacement Surgery with Tissue and Nontissue Prosthetic Valves

Figure 4. Hypertension Treatment Algorithm in Dialysis Patients

Figure 5. Kaplan-Meier Survival Curves by Baseline Troponin Levels

Figure 6. Desaturation and Elongation of the Major Families of Polyunsaturated Fatty Acids

Figure 7. Coronary Event-Free Survival and Apo(a) Phenotypes